Surgical valve technologies

Surgical valve technologies

Abstract Introduction Aortic valve neocuspidization (AVNeo) for trileaflet aortic valve reconstruction using autologous pericardium (Ozaki procedure) depicts an encouraging new

Read More

Surgical valve technologies

Abstract Background Valve surgery guidelines for infective endocarditis (IE) are unchanged over decades and nationwide data about the use of

Read More

Surgical valve technologies

Redefining “low risk”: Outcomes of surgical aortic valve replacement in low-risk patients in the transcatheter aortic valve replacement era Johnston et al

Read More

Surgical valve technologies

Abstract Aims The optimal treatment for severe aortic valve disease complicated with moderate function mitral regurgitation (FMR) remains controversial. Although

Read More

Surgical valve technologies

Abstract Background Isolated tricuspid valve endocarditis (TVE) is a rare disease which is managed medically in most patients. Only in

Read More

Surgical valve technologies

Mitral valve repair versus replacement in patients with rheumatic heart disease ADULT: MITRAL VALVE T Mitral valve repair versus replacement in patients with ADUL rheumatic heart disease Shao-Wei Chen, MD, PhD, a , b 

Read More

Surgical valve technologies

Abstract Objectives Aortic root enlargement (ARE) lowers the risk of patient prosthesis mismatch after surgical aortic valve replacement (SAVR) in

Read More

Surgical valve technologies

Abstract Background and Aims Transcatheter aortic valve replacement (TAVR) is the mainstay of treatment of inoperable and severe high‐risk aortic

Read More

Surgical valve technologies

Influence of surgical volume on outcomes in low-risk patients undergoing isolated surgical aortic valve replacement Adult: Aortic Valve Dewey et al Inï¬ uence of surgical volume on outcomes in low-risk patients undergoing isolated surgical aortic

Read More

Surgical valve technologies

Abstract Aims Low-gradient aortic stenosis is a challenging entity that needs accurate preoperative evaluation. For this high-risk patient population, ad

Read More

1 8 9 10 11 12 13